Matthew Beard
Matthew Beard publishes mostly in Neurology, Molecular Biology and Cellular and Molecular Neuroscience, on topics such as Botulinum Toxin and Related Neurological Disorders, Neurological disorders and treatments and Hereditary Neurological Disorders.
- World rank
- #3,492,767 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #230,605 of 367,258
- Works
- 70
- Citations
- 1.5k
- Citations per work
- 22.1
What does Matthew Beard research?
Matthew Beard's work is mostly in Medicine (44%), Biochemistry, Genetics and Molecular Biology (28%), Neuroscience (13%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3143.6%
- Medicine3143.6%
- Life Sciences2840.6%
- Everything else1115.8%
- 1Neurology38% of their works
- 2Molecular Biology18% of their works
- 3Cellular and Molecular Neuroscience13% of their works
- 4Cell Biology10% of their works
- 5Pharmacology3% of their works
- 6Cardiology and Cardiovascular Medicine3% of their works
Research topics
- Botulinum Toxin and Related Neurological Disorders
- Neurological disorders and treatments
- Hereditary Neurological Disorders
- Cellular transport and secretion
- Phosphodiesterase function and regulation
- Receptor Mechanisms and Signaling
- Cholinesterase and Neurodegenerative Diseases
- Lipid Membrane Structure and Behavior
Which keywords describe Matthew Beard's research?
The keywords of their largest research topics: Neurological Disorders, Toxicology, Botulinum Toxin, Neurotoxins, Deep Brain Stimulation, Parkinson's Disease, Charcot-Marie-Tooth Disease and Hereditary Spastic Paraplegia.
- Lipid Rafts
- Acetylcholinesterase
- Crystal Structure
- Cyclic Nucleotide Phosphodiesterases
- Membrane Fusion
- Hereditary Spastic Paraplegia
- Parkinson's Disease
- Neurotoxins
- Toxicology
- Neurological Disorders
- Botulinum Toxin
- Deep Brain Stimulation
- Charcot-Marie-Tooth Disease
- Endocytosis
- Pharmacology
- cAMP Signaling
- G-Protein-Coupled Receptors
- Cholinesterase Inhibitors
- Membrane Lipids
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Neurological Disorders622 topics
- Toxicology392 topics
- Botulinum Toxin341 topic
- Neurotoxins341 topic
- Deep Brain Stimulation281 topic
- Parkinson's Disease281 topic
- Charcot-Marie-Tooth Disease171 topic
- Hereditary Spastic Paraplegia171 topic
- Endocytosis121 topic
- Membrane Fusion121 topic
- Pharmacology122 topics
- Cyclic Nucleotide Phosphodiesterases111 topic
- cAMP Signaling111 topic
- Crystal Structure71 topic
- G-Protein-Coupled Receptors71 topic
- Acetylcholinesterase51 topic
- Cholinesterase Inhibitors51 topic
- Lipid Rafts41 topic
- Membrane Lipids41 topic
Where does Matthew Beard work?
Matthew Beard's main affiliation in the publication record is Ipsen (United Kingdom), United Kingdom.
How many publications and citations does Matthew Beard have?
OpenAlex counts 70 works and 1,545 citations for Matthew Beard, an h-index of 18, ranking #3,492,767 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Matthew Beard
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Matthew Beard. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.